Long Galena Biopharma: Creating A New Breast Cancer Treatment Alternative

Clearly there is a great need for an alternative form of treatment for many thousands of women. Enter NeuVax, which targets HER2-positive patients (HER2 1+ and 2+) who achieve remission with current standard of care, but have no available HER2-targeted …
See all stories on this topic »